Table: begin end state 1 11 non-cytoplasmic 12 31 transmembrane 32 58 cytoplasmic 59 83 transmembrane 84 88 non-cytoplasmic 89 109 transmembrane 110 137 cytoplasmic 138 158 transmembrane 159 170 non-cytoplasmic 171 193 transmembrane 194 202 cytoplasmic 203 224 transmembrane 225 232 non-cytoplasmic 233 255 transmembrane 256 293 cytoplasmic 294 315 transmembrane 316 338 non-cytoplasmic 339 361 transmembrane 362 377 cytoplasmic 378 403 transmembrane 404 406 non-cytoplasmic 407 427 transmembrane 428 483 cytoplasmic
Input: >AO353_09955 FitnessBrowser__pseudo3_N2E3:AO353_09955 MLEVINDFLSGKVLIVLIVGLGSYFTIRSRFVQLRHFLHMFSVFKESLRSSSEQLSSFQA LMLSLAGRVGAGNIAGVGIAVTLGGPGAVFWMWVTALVGMSSSFFECSLGQLYKRCDSEG QYRGGPSYYIQHGLQKRWLGMIMAFLLLVTFGFAFNGLQSHAVTHSLNNAFGLNTTYTGL GLAVLLGLVFIGGIKRIAKVADLLVPVKTLVYIGVTIYVIVLQFDHVPGMLMTIVKSAFG LDQAFGGLIGSAIVMGVKRGVFANEAGLGSAPNVAAVASVEHPVAQGVVQAFSVFLDTFV ICTCTALLILLSGFYTPGFEGDGIALTQNSLAAVVGDWGRMFISVALALFVFTSILYNYY LGESNLRFLVGENRKVLIGYRALVLALIFWGAIENLSTVFAFADITMTMLAFVNLIALFL LFNVGMRILNDYDAQRRAGIKTPVFDSSKFPDLDLDLKAWPANPPAAAPKSEAEPQGVTA AQR
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server